Suppr超能文献

相似文献

1
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12087-92. doi: 10.1073/pnas.0704672104. Epub 2007 Jul 5.
4
An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer.
Cancer Res. 2010 Apr 1;70(7):2707-17. doi: 10.1158/0008-5472.CAN-09-4299. Epub 2010 Mar 16.
5
Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
J Obstet Gynaecol Res. 2007 Apr;33(2):103-13. doi: 10.1111/j.1447-0756.2007.00492.x.
7
Role of IL-10 in immune suppression in cervical cancer.
Indian J Biochem Biophys. 2007 Oct;44(5):350-6.
10
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

引用本文的文献

1
Targeting immune microenvironment in cervical cancer: current research and advances.
J Transl Med. 2025 Aug 8;23(1):888. doi: 10.1186/s12967-025-06896-3.
2
Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas.
Cell Rep Med. 2025 Jun 17;6(6):102149. doi: 10.1016/j.xcrm.2025.102149. Epub 2025 May 23.
3
The role of tumor-associated macrophages in HPV induced cervical cancer.
Front Immunol. 2025 Apr 8;16:1586806. doi: 10.3389/fimmu.2025.1586806. eCollection 2025.
4
The immune microenvironment of cancer of the uterine cervix.
Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.
6
TIME Is Ticking for Cervical Cancer.
Biology (Basel). 2023 Jun 30;12(7):941. doi: 10.3390/biology12070941.
8
Human Virome in Cervix Controlled by the Domination of Human Papillomavirus.
Viruses. 2022 Sep 17;14(9):2066. doi: 10.3390/v14092066.
9
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct.
J Clin Med. 2022 Aug 18;11(16):4825. doi: 10.3390/jcm11164825.
10
Proteases and HPV-Induced Carcinogenesis.
Cancers (Basel). 2022 Jun 21;14(13):3038. doi: 10.3390/cancers14133038.

本文引用的文献

2
Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.
Adv Drug Deliv Rev. 2006 Oct 1;58(8):916-30. doi: 10.1016/j.addr.2005.11.003. Epub 2006 Aug 12.
3
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
J Clin Invest. 2005 Dec;115(12):3623-33. doi: 10.1172/JCI25947. Epub 2005 Nov 23.
5
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.
Blood. 2006 Jan 15;107(2):628-36. doi: 10.1182/blood-2005-07-2737. Epub 2005 Sep 22.
7
Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.
Science. 2005 Aug 26;309(5739):1380-4. doi: 10.1126/science.1113401.
10
Antigen-specific CD4+ regulatory T cells in cancer: implications for immunotherapy.
Microbes Infect. 2005 Jun;7(7-8):1056-62. doi: 10.1016/j.micinf.2005.03.028. Epub 2005 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验